Untreated newly diagnosed essential hypertension is associated with nonalcoholic fatty liver disease in a population of a hypertensive center

References

• SmithBWAdamsLANon-alcoholic fatty liver diseaseCrit Rev Clin Lab Sci2011489711321875310
   PubMed Web of Science ®Google Scholar
• GossardAALindorKDCurrent therapies for nonalcoholic fatty liver diseaseDrugs Today (Barc)20114791592222348916
   PubMed Web of Science ®Google Scholar
• WongVWWongGLChoiPCDisease progression of nonalcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 yearsGut20105996997420581244
   PubMed Web of Science ®Google Scholar
• OngJPPittsAYounossiZMIncreased overall mortality and liver-related mortality in non-alcoholic fatty liver diseaseJ Hepatol20084960861218682312
   PubMed Web of Science ®Google Scholar
• StepanovaMYounossiZMIndependent association between nonalcoholic fatty liver disease and cardiovascular disease in the US populationClin Gastroenterol Hepatol20121064665022245962
   PubMed Web of Science ®Google Scholar
• NseirWShalataAMarmorAAssyNMechanisms linking nonalcoholic fatty liver disease with coronary artery diseaseDig Dis Sci201156123439344921655948
   PubMed Web of Science ®Google Scholar
• Lizardi-CerveraJAguilar-ZapataDNonalcoholic fatty liver disease and its association with cardiovascular diseaseAnn Hepatol20098Suppl 1S40S4319381123
   PubMed Web of Science ®Google Scholar
• GarianiKPhilippeJJornayvazFRNon-alcoholic fatty liver disease and insulin resistance: from bench to bedsideDiabetes Metab201339162623266468
   PubMed Web of Science ®Google Scholar
• MarchesiniGBugianesiEForlaniGNonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology20033791792312668987
   PubMed Web of Science ®Google Scholar
• MarchesiniGMarzocchiRMetabolic syndrome and NASHClin Liver Dis20071110511717544974
   PubMedGoogle Scholar
• VasuntaRLKesäniemiYAYlitaloASUkkolaOHHigh ambulatory blood pressure values associated with non-alcoholic fatty liver in middle-aged adultsJ Hypertens2012302015201922940679
   PubMed Web of Science ®Google Scholar
• BedogniGMiglioliLMasuttiFTiribelliCMarchesiniGBellentaniSPrevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver studyHepatology200542445215895401
   PubMed Web of Science ®Google Scholar
• GeorgescuEFAngiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?Adv Ther2008251141117418972077
   PubMed Web of Science ®Google Scholar
• FogariRMaffioliPMugelliniAZoppiALazzariPDerosaGEffects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosisEur J Gastroenterol Hepatol20122416417122081005
   PubMed Web of Science ®Google Scholar
• YamamotoEDongYFKataokaKOlmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis regulating kinase-1 inhibitionEur J Pharmacol20085882–331632418501344
   PubMed Web of Science ®Google Scholar
• KitamuraKTadaSNakamotoNRho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosisJ Gastroenterol Hepatol200722112022203317914985
   PubMed Web of Science ®Google Scholar
• KuritaSTakamuraTOtaTOlmesartan ameliorates a dietary rat model of non-alcoholic steatohepatitis through its pleiotropic effectsEur J Pharmacol20085882–331632418501344
   PubMed Web of Science ®Google Scholar
• LeeBTAhmedFAHammLLAssociation of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney diseaseBMC Nephrol2015167726025192
   PubMed Web of Science ®Google Scholar
• AnguloPMedical progress: nonalcoholic fatty liver diseaseN Eng J Med200234612211231
   PubMed Web of Science ®Google Scholar
• ParkSHKimBIKimSHKimHJParkDIChoYKBody fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight menJ Am Coll Nutr20072632132617906183
   PubMed Web of Science ®Google Scholar
• DouketisJDParadisGKellerHMartineauCCanadian guidelines for body weight classification in adults: application in clinical practice to screen for overweight and obesity and to assess disease riskCMAJ2005172899599815824401
   PubMed Web of Science ®Google Scholar
• SanyalAJfor American Gastroenterological AssociationAGA technical review on nonalcoholic fatty liver diseaseGastroenterology200212351705172512404245
   PubMedGoogle Scholar
• ESH/ESC Task Force for the Management of Arterial Hypertension2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial HypertensionJ Hypertens201331101925193824107724
   PubMed Web of Science ®Google Scholar
• O’BrienETwenty-four-hour ambulatory blood pressure measurement in clinical practice and research: a critical review of a technique in need of implementationJ Intern Med2011269547849521281363
   PubMed Web of Science ®Google Scholar
• O’BrienEParatiGStergiouGEuropean Society of Hypertension Working Group on Blood Pressure MonitoringEuropean Society of Hypertension position paper on ambulatory blood pressure monitoringJ Hypertens20133191731176824029863
   PubMed Web of Science ®Google Scholar
• FlackJMYunisCTherapeutic implications of the epidemiology and timing of myocardial infarction and other cardiovascular diseasesJ Hum Hypertens199711123289111153
   PubMed Web of Science ®Google Scholar
• BrandenbergerGFolleniusMGoichotBTwenty-four-hour profiles of plasma renin activity in relation to the sleep-wake cycleJ Hypertens19941232772838021481
   PubMed Web of Science ®Google Scholar
• ZhouMSSchulmanIHRaijLRole of angiotensin II and oxidative stress in vascular insulin resistance linked to hypertensionAm J Physiol Heart Circ Physiol2009296H833H83919151253
   PubMed Web of Science ®Google Scholar
• Te RietLvan EschJHRoksAJvan den MeirackerAHDanserAHHypertension: renin-angiotensin-aldosterone system alterationsCirc Res2015116696097525767283
   PubMed Web of Science ®Google Scholar
• MoonJYRecent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertensionElectrolyte Blood Press2013112414524627703
   PubMedGoogle Scholar
• ManriqueCLastraGGardnerMSowersJRThe renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stressMed Clin North Am200993356958219427492
   PubMed Web of Science ®Google Scholar
• FrantzEDPenna-de-CarvalhoABatista TdeMAguilaMBMandarim-de-LacerdaCAComparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 miceMetab Syndr Relat Disord201412419120124517411
   PubMed Web of Science ®Google Scholar
• PaschosPTziomalosKNonalcoholic fatty liver disease and the renin-angiotensin system: implications for treatmentWorld J Hepatol201241232733123355909
   PubMedGoogle Scholar
• WeiYClarkSEThyfaultJPOxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 ratsAm J Pathol200917441329133719246643
   PubMed Web of Science ®Google Scholar
• DixonJBBhathalPSO’BrienPENonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obeseGastroenterology200112119110011438497
   PubMed Web of Science ®Google Scholar
• McGrathBPfor National Blood Pressure Advisory Committee of the National Heart Foundation of AustraliaAmbulatory blood pressure monitoringMed J Aust20021761258859212064958
   PubMed Web of Science ®Google Scholar
• Matthew MorrisEFletcherJAThyfaultJPScott RectorRThe role of angiotensin II in nonalcoholic steatohepatitisMol Cell Endocrinol20133781–2294022579612
   PubMed Web of Science ®Google Scholar
• JosephAESaverymuttuSHAl-SamSCookMGMaxwellJDComparison of liver histology with ultrasonography in assessing diffuse parenchymal liver diseaseClin Radiol19914326311999069
   PubMed Web of Science ®Google Scholar
• HultcrantzRGabrielssonNPatients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsyJ Intern Med19932337128429291
   PubMed Web of Science ®Google Scholar
• LaBrecqueDAbbasZAnaniaFWGO Global Guidelines Library c2006–2015. Nonalcoholic Fatty Liver Disease and Nonalcoholic SteatohepatitisMilwaukee, WIWorld Gastroenterology Organisation62012 Available from: http://www.worldgastroenterology.org/assets/export/userfiles/2012_NASH%20and%20NAFLD_Final_long.pdfAccessed November 19, 2015
   Google Scholar